NeOnc Technologies Holdings, Inc. announced that the Department of Health – Abu Dhabi (DOH) has granted Investigational New Drug (IND) status for NEO100, an intranasally administered purified perillyl alcohol formulation for non-invasive nose-to-brain drug delivery. NeOnc Technologies Holdings, Inc. is a biotechnology company focused on drug delivery technologies andiation.</div>
